Novo Nordisk A/S
Explore Novo Nordisk A/S
Core profile pages, annual revenue records, and related research hubs for this company.
Novo Nordisk A/S
Explore Novo Nordisk A/S
Core profile pages, annual revenue records, and related research hubs for this company.
Business Model Analysis
Annual Revenue: DKK 309.1B (about $46.0B)
Novo Nordisk makes money by developing and selling prescription medicines for diabetes, obesity, rare blood disorders, rare endocrine disorders, and related chronic diseases.
Novo Nordisk A/S's growth strategy centers on this advantage: Novo Nordisk's advantage is deep GLP-1 science, diabetes and obesity scale, global manufacturing, payer experience, and one of the world's strongest chronic-care franchises.